Opal Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-75
Closed -$22K 339
2026
Q1
$22K Buy
+75
New +$24.6K 0.01% 580
2025
Q3
Sell
-360
Closed -$140K 305
2025
Q2
$140K Buy
360
+307
+579% +$123K 0.04% 233
2025
Q1
$23.1K Buy
+53
New +$21.3K 0.01% 504
2024
Q3
Sell
-52
Closed -$28.2K 486
2024
Q2
$28.2K Buy
+52
New +$27.5K 0.01% 432

Other funds holding ELV

Opal Wealth Advisors's ELV Position: Q2 2026 in Review

Opal Wealth Advisors sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 75 shares — an estimated $22K sold.

Opal Wealth Advisors first reported a position in ELV in Q2 2024 and held it in 4 quarters. The position peaked at $140K in Q2 2025. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Opal Wealth Advisors reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Opal Wealth Advisors sold 75 Elevance Health shares in Q2 2026, an estimated $22K.
  • Opal Wealth Advisors first reported a position in Elevance Health in Q2 2024 and held it in 4 quarters.
  • Opal Wealth Advisors's Elevance Health position peaked at $140K in Q2 2025.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.